Table 3.
Variable | Univariate | Multivariate | ||||
---|---|---|---|---|---|---|
HR | 95% CI | p value | HR | 95% CI | p value | |
Age (≥66 years versus <66 years) | 0.86 | 0.5–1.5 | 0.58 | |||
Gender (female versus male) | 1.1 | 0.6–1.9 | 0.71 | |||
Tumor location (nonhead versus head) | 1.3 | 0.7–2.2 | 0.37 | |||
Karnofsky performance status score (100–80% versus 70–60%) | 0.5 | 0.2–1 | 0.08 | |||
CA19.9 basal (≥59 ULN versus <59 ULN) | 0.8 | 0.4–1.5 | 0.5 | |||
CA19.9 reduction (<50% versus ≥50%) | 2.44 | 1.3–4.6 | 0.006 | 3.22 | 1.6–6.4 | 0.001 |
Stent (yes versus no) | 0.69 | 0.37–1.29 | 0.24 | |||
N/L ratio (≥5 versus <5) | 1.9 | 1.0–3.4 | 0.036 | 2.77 | 1.3–5.7 | 0.006 |
Liver metastasis | 0.5 | 0.3–0.9 | 0.038 | 0.5 | 0.2–1.0 | 0.05 |